2020
DOI: 10.1016/j.ejmech.2020.112669
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(23 citation statements)
references
References 50 publications
1
22
0
Order By: Relevance
“…Finally, the introduction of a nitrile group into the benzyl group of 18 would provide the target molecule 1 . Additional demonstrations for two other drug-like molecules, kwakhurin 47 and α7 nicotinic acetylcholine receptor silent agonist, 48 are shown in Figure 5 c,d and Figure 5 e,f, respectively. To confirm the difference in each step’s score between ReTReK with and without retrosynthesis knowledge, four retrosynthesis knowledge scores were added to each step in the synthetic routes ( Figure S5 ).…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…Finally, the introduction of a nitrile group into the benzyl group of 18 would provide the target molecule 1 . Additional demonstrations for two other drug-like molecules, kwakhurin 47 and α7 nicotinic acetylcholine receptor silent agonist, 48 are shown in Figure 5 c,d and Figure 5 e,f, respectively. To confirm the difference in each step’s score between ReTReK with and without retrosynthesis knowledge, four retrosynthesis knowledge scores were added to each step in the synthetic routes ( Figure S5 ).…”
Section: Resultsmentioning
confidence: 98%
“… Comparison of the synthetic route for three target compounds (a,b) hepatitis B virus capsid inhibitor, 45 (c,d) kwakhurin, 47 and (e,f) α7 nicotinic acetylcholine receptor silent agonist 48 ) found by ReTReK with retrosynthesis knowledge (a, c, and e) and the corresponding route found without retrosynthesis knowledge (b, d, and f). …”
Section: Resultsmentioning
confidence: 99%
“…ACh-evoked currents potentiated by GAT107 or B-973B showed reduced calcium permeability, although intracellular calcium was observed to rise [ 91 ]. Silent agonists can overcome this reduced calcium permeability under conditions that do not require ion flux for signaling [ 92 ].…”
Section: Positive Allosteric Modulators (Pams) and Silent Agonists Of The Nachrmentioning
confidence: 99%
“…The combination of nicotine and methyllycaconitine, an α7 nAChR antagonist, result in a form of LTD that can be blocked by dihydro-β-erythroidine. nAChR intervention in nicotine-facilitated synaptic plasticity involves the excitatory glutamatergic synapse [ 92 ]. The nicotine-facilitated LTP in lead-exposed rats is blocked by the NMDA-R antagonist d-(−)-2-amino-5-phosphonopentanoic acid, or picrotoxin, an antagonist of GABA A receptors, leading Wang and coworkers to suggest that nicotine-facilitated synaptic plasticity is due to the activation of NMDARs by presynaptic nAChR-mediated disinhibition of pyramidal cells [ 100 ].…”
Section: Dendritic Spines and Nachr-mediated Synaptic Plasticitymentioning
confidence: 99%
“…In the last decade, some of us have been active in the study and characterization of α7 nAChRs and their therapeutic potential [16][17][18][19][20][21][22][23][24][25][26]. In this framework, we designed, synthesized and tested (R)-(-)-3-methoxy-1-oxa-2,7-diaza-7,10-ethanospiro [4.5]dec-2-ene sesquifumarate (from now on identified as ICH3), which behaves as a selective orthosteric partial agonist of the α7 receptor subtype [19].…”
Section: Introductionmentioning
confidence: 99%